Publication | Closed Access

Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

VaccinationCross-protectionVaccine DevelopmentImmunologyVirologyInfluenza VaccineMf59™-adjuvanted Influenza VaccineVaccine DesignImmunotherapyMedicineHaemagglutination-inhibiting Antibody ActivityInfluenza VirusesInfluenza Vaccines